(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 39.21%21.52B | 41.64%15.88B | 32.50%9.68B | 52.90%5.36B | 77.44%15.46B | 76.96%11.21B | 81.34%7.3B | 70.61%3.51B | 39.18%8.71B | 57.78%6.34B |
Operating income | 39.21%21.52B | 41.64%15.88B | 32.50%9.68B | 52.90%5.36B | 77.44%15.46B | 76.96%11.21B | 81.34%7.3B | 70.61%3.51B | 39.18%8.71B | 57.78%6.34B |
Operating expenses | -39.70%-16.83B | -43.20%-12.51B | -38.54%-7.83B | -58.74%-4.37B | -114.37%-12.05B | -124.57%-8.74B | -151.67%-5.65B | -196.64%-2.76B | -56.08%-5.62B | -61.07%-3.89B |
Gross profit | 37.52%4.69B | 36.15%3.37B | 11.88%1.85B | 31.53%990.84M | 10.34%3.41B | 1.24%2.48B | -7.23%1.65B | -33.20%753.3M | 16.29%3.09B | 52.80%2.45B |
Selling expenses | -0.73%-119.75M | 27.70%-53.21M | 17.02%-41.2M | -76.13%-33.64M | -38.67%-118.88M | 11.69%-73.59M | 12.03%-49.65M | -1.18%-19.1M | -79.97%-85.72M | 60.84%-83.33M |
Administrative expenses | -8.88%-302.2M | -1.67%-203.16M | 4.65%-120.52M | -12.98%-70.3M | -25.14%-277.54M | -28.63%-199.83M | -18.00%-126.4M | -8.07%-62.23M | -28.68%-221.78M | -49.56%-155.35M |
Research and development expenses | -14.05%-596.75M | -26.99%-488.8M | -12.34%-286.54M | -56.35%-157.5M | -28.11%-523.23M | -26.94%-384.91M | -27.50%-255.05M | -8.51%-100.73M | -43.45%-408.42M | -72.26%-303.24M |
Profit from asset sales | 20.37%-7.09M | 16.35%-7.82M | 99.11%-81.43K | 97.31%-171.64K | -347.28%-8.9M | -379.06%-9.35M | -863.25%-9.15M | -1,753.11%-6.37M | 119.97%3.6M | 213.78%3.35M |
Revaluation surplus | 134.61%632.85K | 104.06%83.28K | 89.11%-398.64K | 1,365.01%1.64M | -32.23%-1.83M | -17.60%-2.05M | -2,187.45%-3.66M | 93.85%-129.4K | -211.02%-1.38M | -270.91%-1.74M |
-Changes in the fair value of other assets | 134.61%632.85K | 104.06%83.28K | 89.11%-398.64K | 1,365.01%1.64M | -32.23%-1.83M | -17.60%-2.05M | -2,187.45%-3.66M | 93.85%-129.4K | -211.02%-1.38M | -270.91%-1.74M |
Impairment and provision | -208.53%-130.1M | -7.37%-39.62M | 54.95%-15.93M | 25.42%-22.17M | -415.81%-42.17M | -556.69%-36.9M | -235.12%-35.36M | -1,489.74%-29.73M | 113.13%13.35M | 113.93%8.08M |
-Other impairment is provision | -208.53%-130.1M | -7.37%-39.62M | 54.95%-15.93M | 25.42%-22.17M | -415.81%-42.17M | -556.69%-36.9M | -235.12%-35.36M | -1,489.74%-29.73M | 113.13%13.35M | 113.93%8.08M |
Special items of operating profit | 115.53%194.66M | 1.23%58.61M | -11.83%39.73M | -20.98%22.28M | 0.11%90.32M | -11.54%57.9M | 32.85%45.07M | 112.79%28.2M | 189.65%90.22M | 135.08%65.45M |
Operating profit | 47.53%3.53B | 42.24%2.48B | 14.15%1.34B | 26.06%686.64M | -1.59%2.4B | -10.44%1.75B | -19.40%1.17B | -42.97%544.69M | 21.32%2.43B | 85.86%1.95B |
Financing cost | -100.84%-482.89M | -187.53%-274.41M | -103.92%-156.54M | -156.62%-126.61M | -357.81%-240.43M | -1,964.74%-95.43M | -459.53%-76.77M | -1,030.50%-49.34M | 62.89%-52.52M | 92.00%-4.62M |
Special items of earning before tax | 119.37%453.05K | 409.72%585.28K | 386.79%465.37K | 813.05%361.42K | -55.74%-2.34M | -105.14%-188.97K | -106.13%-162.27K | -96.84%39.58K | -116.71%-1.5M | -41.88%3.68M |
Earning before tax | 41.75%3.05B | 33.89%2.21B | 7.93%1.18B | 13.12%560.39M | -9.55%2.15B | -15.30%1.65B | -24.10%1.1B | -48.49%495.39M | 27.02%2.38B | 95.35%1.95B |
Tax | -859.55%-288.78M | -63.33%-238.1M | -4.68%-99.08M | 16.60%-48.94M | 88.44%-30.1M | 36.99%-145.78M | 48.81%-94.65M | 52.63%-58.68M | -6.19%-260.3M | -24.67%-231.36M |
After-tax profit from continuing operations | 30.16%2.76B | 31.04%1.97B | 8.24%1.09B | 17.11%511.45M | 0.13%2.12B | -12.38%1.5B | -20.48%1B | -47.88%436.71M | 30.15%2.12B | 111.50%1.72B |
Earning after tax | 30.16%2.76B | 31.04%1.97B | 8.24%1.09B | 17.11%511.45M | 0.13%2.12B | -12.38%1.5B | -20.48%1B | -47.88%436.71M | 30.15%2.12B | 111.50%1.72B |
Minority profit | --3.34M | --2.66M | --489.99K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 30.00%2.76B | 30.86%1.97B | 8.19%1.08B | 17.11%511.45M | 0.13%2.12B | -12.38%1.5B | -20.48%1B | -47.88%436.71M | 30.15%2.12B | 111.50%1.72B |
Basic earnings per share | 25.25%1.24 | 28.57%0.9 | 8.51%0.51 | 20.00%0.24 | 0.00%0.99 | -12.50%0.7 | -20.34%0.47 | -50.00%0.2 | 19.28%0.99 | 90.48%0.8 |
Diluted earnings per share | 25.25%1.24 | 30.43%0.9 | 15.91%0.51 | 20.00%0.24 | 0.00%0.99 | -13.75%0.69 | -25.42%0.44 | -50.00%0.2 | 22.22%0.99 | 90.48%0.8 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data